Antibiotics, Nosocomial Infection and the Evidence: Update 2024

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

This intermediate-level session describes the epidemiology of common nosocomial pathogens and the optimal use of appropriate antibiotic therapy to effectively treat infection while practicing antimicrobial stewardship. We review current evidence-based pharmacological guidelines, side effects, medication monitoring, and treatment goals for serious infections including catheter-associated urinary tract infections, central line-associated bloodstream infection, ventilator-associated pneumonia, hospital- and community-acquired pneumonia, necrotizing and severe soft tissue infections and Clostridium difficile infection management. This is all about clinical practice. Pharmacology content = 90%

Objectives

Explain and analyze current recommendations for the diagnosis and treatment of ventilator-associated pneumonia, community- and hospital-acquired pneumonia, urinary tract infection and bloodstream infections.
Describe the prevalence of healthcare-association infections and multidrug-resistant organisms in the acute care setting and how this influences antibiotic prescribing practices.
Choose appropriate antimicrobial therapy for at least three severe infections in the inpatient environment.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.